用于治疗成人部分发作性癫痫新药-cenobamate  

A new drug in treating adults with partial-onset seizures-cenobamate

作　　者：曹友林 段志辉 王振国 谢军 CAO You-lin;DUAN Zhi-hui;WANG Zhen-guo;XIE Jun(Neurosurgery,Affiliated Hospital of Panzhihua University,Panzhihua 617000,China;Emergency Department,Affiliated Hospital of Panzhihua University,Panzhihua 617000,China)

机构地区：[1]攀枝花学院附属医院神经外科,四川攀枝花617000 [2]攀枝花学院附属医院急诊科,四川攀枝花617000

出　　处：《实用药物与临床》2020年第11期1047-1051,共5页Practical Pharmacy and Clinical Remedies

摘　　要：Cenobamate(YKP-3089)是一种治疗部分发作癫痫的药物,该药于2019年11月21日获得美国食品药品管理局(FDA)批准上市,商品名:XCOPRI,用于治疗成人部分发作性癫痫病。本文就cenobamate的用法用量、作用机制、临床研究、药动学、药物相互作用、不良反应及安全性作一介绍。Cenobamate(YKP-3089)is a drug for the treatment of partial epilepsy.The drug was approved by the US Food and Drug Administration(FDA)on November 21,2019 and is marketed as XCOPRI to be used for adult patients.This article introduces the usage and dosage of cenobamate,its mechanism of action,clinical research,pharmacokinetics,drug interaction,adverse reactions and safety.

关 键 词：Cenobamate 部分发作性癫痫 不良反应 药动学 

分 类 号：R971.6[医药卫生—药品]